Company intelligence / Profile preview

ULU

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Ulu Diagnostics is a point-of-care diagnostics company focused on developing rapid, high-sensitivity testing solutions for infectious diseases and critical care. The company's proprietary platform aims to bridge the gap between laboratory-grade accuracy and the speed required for immediate clinical decision-making. By utilizing advanced biosensing technology, Ulu Diagnostics seeks to provide healthcare providers with actionable results in minutes rather than hours. Their primary focus includes the early detection of sepsis and respiratory pathogens to improve patient outcomes and antimicrobial stewardship.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic platformPoint-of-care testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on ULU.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ULU.

Explore the full profile